Low-birth-weight, but not catch-up growth, correlates with insulin resistance and resistin level in SGA infants at 12 months

References

• Barker DJP. Fetal origins of coronary heart disease. BMJ 1995;311:171–4
   PubMed Web of Science ®Google Scholar
• Levy-Marshal C, Jaquet D. Long-term metabolic consequences of being born small for gestational age. Pediatr Diabetes 2004;5:147–53
   PubMed Web of Science ®Google Scholar
• Hales CN, Barker DJ. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595–601
   PubMed Web of Science ®Google Scholar
• Morley R, Dwyer T. Fetal origins of adult disease? Clin Exp Pharmacol Physiol 2001;28:962–6
   PubMed Web of Science ®Google Scholar
• Soto N, Bazaes RA, Peña V, et al. Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort. J Clin Endocrinol Metab 2003;88:3645–50
   PubMed Web of Science ®Google Scholar
• Dizdarer C, Korkmaz HA, Büyükocak ÖM, et al. Impact of insulin resistance on insulin-like growth factor-1/insulin like growth factor-binding protein-3 axis and on early weight gain in small for gestational age infants. J Clin Res Pediatr Endocrinol 2013;5:104–9
   PubMed Web of Science ®Google Scholar
• Ibáñez L, Ong K, Dunger DB, et al. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006;91:2153–8
   PubMed Web of Science ®Google Scholar
• Mericq V, Ong KK, Bazaes R, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia 2005;48:2609–14
   PubMed Web of Science ®Google Scholar
• Mittelman SD, Van Citters GW, Kirkman EL, et al. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 2002;51:755–61
   PubMed Web of Science ®Google Scholar
• Milovanovic I, Njuieyon F, Deghmoun S, et al. SGA children with moderate catch-up growth are showing the impaired insulin secretion at the age of 4. PLoS One 2014;9:e100337
   PubMed Web of Science ®Google Scholar
• Deng HZ, Deng H, Su Z, et al. Insulin resistance and adiponectin levels are associated with height catch-up growth in pre-pubertal Chinese individuals born small for gestational age. Nutr Metab (Lond) 2012;9:107
   PubMed Web of Science ®Google Scholar
• Ekelund U, Ong K, Linné Y, et al. Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES). Am J Clin Nutr 2006;83:324–30
   PubMed Web of Science ®Google Scholar
• Tzoulaki I, Sovio U, Pillas D, et al. Relation of immediate postnatal growth with obesity and related metabolic risk factors in adulthood: the northern Finland birth cohort 1966 study. Am J Epidemiol 2010;171:989–98
   PubMed Web of Science ®Google Scholar
• McCarthy A, Hughes R, Tilling K, et al. Birth weight; postnatal, infant, and childhood growth; and obesity in young adulthood: evidence from the Barry Caerphilly Growth Study. Am J Clin Nutr 2007;86:907–13
   PubMed Web of Science ®Google Scholar
• Milovanovic I, Njuieyon F, Deghmoun S, et al. Innate small babies are metabolically healthy children. J Clin Endocrinol Metab 2012;97:4407–13
   PubMed Web of Science ®Google Scholar
• Evagelidou EN, Kiortsis DN, Bairaktari ET, et al. Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care 2006;29:1197–201
   PubMed Web of Science ®Google Scholar
• Ong KK, Ahmed ML, Emmett PM, et al. Association between postnatal accelerated growth and obesity in childhood: prospective cohort study. BMJ 2000;320:967–71
   PubMed Web of Science ®Google Scholar
• Rodriguez G, Samper MP, Olivares JL, et al. Skinfold measurements at birth: sex and anthropometric influence. Arch Dis Child Fetal Neonatal Ed 2005;90:F273–5
   PubMed Web of Science ®Google Scholar
• Altman D. Sample size. In: Practical statistics for medical research. London: Chapman and Hall; 1994:456–460
   Google Scholar
• Beltrand J, Nicolescu R, Kaguelidou F, et al. Catch-up growth following fetal growth restriction promotes rapid restoration of fat mass but without metabolic consequences at one year of age. PLoS One 2009;4:e5343
   PubMed Web of Science ®Google Scholar
• Díaz M, Bassols J, López-Bermejo A, et al. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children. Pediatr Diabetes 2015;16:538–45
   PubMed Web of Science ®Google Scholar
• Polo Perucchin P, Traggiai C, Calevo MG, et al. Auxological and metabolic study in small for gestational age children during 2 years follow-up. J Matern Fetal Neonatal Med 2011;24:381–7
   PubMed Web of Science ®Google Scholar
• Morgan AR, Thompson JM, Murphy R, et al. Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. BMC Med Genet 2010;11:125
   PubMed Web of Science ®Google Scholar
• Freathy RM, Bennett AJ, Ring SM, et al. Type 2 diabetes risk alleles are associated with reduced size at birth. Diabetes 2009;58:1428–33
   PubMed Web of Science ®Google Scholar
• Mitchell EA, Robinson E, Clark PM, et al. Maternal nutritional risk factors for small for gestational age babies in a developed country: a case-control study. Arch Dis Child Fetal Neonatal Ed 2004;89:F431–5
   PubMed Web of Science ®Google Scholar
• Giapros VI, Challa AS, Cholevas VL, et al. Vitamin D levels and insulin resistance in children born with severe growth restriction. Horm Metab Res 2013;45:226–30
   PubMed Web of Science ®Google Scholar
• Lemos JO, Rondó PH, Pereira JA, et al. The relationship between birth weight and insulin resistance in childhood. Br J Nutr 2010;103:386–92
   PubMed Web of Science ®Google Scholar
• Meas T, Deghmoun S, Alberti C, et al. Independent effects of weight gain and fetal programming on metabolic complications in adults born small for gestational age. Diabetologia 2010;53:907–13
   PubMed Web of Science ®Google Scholar
• Reinehr T, Kleber M, Toschke AM. Small for gestational age status is associated with metabolic syndrome in overweight children. Eur J Endocrinol 2009;160:579–84
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307–12
   PubMed Web of Science ®Google Scholar
• Shojima N, Sakoda H, Ogihara T, et al. Humoral regulation of resistin expression in 3T3 L1 and mouse adipose cells. Diabetes 2002;51:1737–44
   PubMed Web of Science ®Google Scholar
• Fukui Y, Motojima K. Expression of resistin in the adipose tissues modulated by various factors including peroxisome proliferator-activated receptor agonists. Diabetes Obes Metab 2002;4:342–5
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth. Neonatology 2008;93:153–7
   PubMed Web of Science ®Google Scholar
• Willemsen RH, van Dijk M, de Rijke YB, et al. Effect of growth hormone therapy on serum adiponectin and resistin levels in short, small-for-gestational-age children and associations with cardiovascular risk parameters. J Clin Endocrinol Metab 2007;92:117–23
   PubMed Web of Science ®Google Scholar
• Huang F, Del-Río-Navarro BE, Pérez-Ontiveros JA, et al. Effect of six-month lifestyle intervention on adiponectin, resistin and soluble tumor necrosis factor-α receptors in obese adolescents. Endocr J 2014;61:921–31
   PubMed Web of Science ®Google Scholar
• Gerber M, Boettner A, Seidel B, et al. Serum resistin levels of obese and lean children and adolescents: biochemical analysis and clinical relevance. J Clin Endocrinol Metab 2005;90:4503–9
   PubMed Web of Science ®Google Scholar
• Cabrera de León A, Almeida González D, González Hernández A, et al. Relationships between serum resistin and fat intake, serum lipid concentrations and adiposity in the general population. J Atheroscler Thromb 2014;21:454–62
   PubMed Web of Science ®Google Scholar
• Asgary S, Samsam Shariat SZ, Ghorbani A, et al. Relationship between serum resistin concentrations with metabolic syndrome and its components in an Iranian population. Diabetes Metab Syndr 2015;9:266–70
   PubMedGoogle Scholar
• Kushiyama A, Sakoda H, Oue N, et al. Resistin-like molecule β is abundantly expressed in foam cells and is involved in atherosclerosis development. Arterioscler Thromb Vasc Biol 2013;33:1986–93
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487–95
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57–63
   PubMed Web of Science ®Google Scholar